Skip to main content

JPMORGAN CHASE & CO

Position in LGND — Ligand Pharmaceuticals Inc

CIK 19617 NEW YORK, NY

Position in LGND

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$23,091,004
+$5,866,403 QoQ
Shares Held
73,052
-15.3% QoQ
Ownership
0.366%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 415 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 71% Shared 0% None 29%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,196,194 across 425 Biotechnology names. LGND ranks #57 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LGND

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $23,091,004 73,052
2026-03-31 $17,224,601 86,274
2025-12-31 $10,699,468 56,590
2025-09-30 $7,035,644 39,718
2025-06-30 $4,321,542 38,015
2025-03-31 $4,248,915 40,412
2024-12-31 $4,046,089 37,761
2024-09-30 $5,650,178 56,451
2024-06-30 $5,373,425 63,772
2024-03-31 $3,655,436 50,006
2023-12-31 $4,490,816 62,879
2023-09-30 $3,608,079 60,215
2023-06-30 $2,576,419 35,734
2023-03-31 $3,537,424 48,089
2022-12-31 $2,594,044 38,833
2022-09-30 $3,453,438 40,105
2022-06-30 $3,528,558 39,549
2022-03-31 $4,674,859 41,558
2021-12-31 $6,166,502 39,923
2021-09-30 $5,582,268 40,068
2021-06-30 $7,481,371 57,027
2021-03-31 $6,923,209 45,413
2020-12-31 $4,904,970 49,321
2020-09-30 $4,354,215 45,680
2020-06-30 $2,553,645 22,831
2020-03-31 $1,805,270 24,825